INTRODUCTION
Medicinal plants have become of interest in recent years due to their prospects in meeting the health needs of mankind. [1] [2] [3] [4] The long history and widespread use of herbal medicines has always been seen as evidence to this fact.
[] Recently however, these prospects have meant that herbal medicines and other natural products are being subjected to a lot of scrutiny. [6] The major issue of concern with these medicines have been with their quality, safety and efficacy.
The evaluation of the quality of medicinal products is very essential as they are affected by factors that include seasonal changes, harvesting time, cultivation sites, post-harvesting processing, adulterants or substitutes of raw materials and procedures in extraction and preparation. [9] These factors are also known to also have implications on the safety and efficacy of resultant products. [9] [10] The availability of data in the area of quality, safety and efficacy is very scarce for majority of medicinal products in use. [9] A reason assigned for this limitation is the lack of adequate and accepted research methodologies for evaluating natural products. [11] However, steps have been taken by several agencies like the World Health Organisation (WHO) and the International Union of Pure and Applied Chemistry (IUPAC) aimed at addressing these challenges. [12] [13] [14] Significant among these interventions are the recommendations for the standardisation of all medicinal products. [14] Suggestions have been made for the preclinical screening of natural products for safety and efficacy especially when there is the absence of guidelines for carrying out actual clinical assessment. [12] In the current study the polyherbal formulation labelled EAF-2011 from the Centre for Scientific Research into Plant Medicine, Mampong-Akwapem and used in the management of superficial fungal diseases was evaluated. The product formulated with five plants has no previous documentation on its quality and safety.
METHODOLOGY

Plant used in the study
The plants in the formulation were the dried leaves of Alchorneacordifolia(Schum. &Thonn.)Muell.Arg. (Euphorbiaceae), the dried leaves of Psidiumguajava(Linn) (Mrytaceae), the dried whole plant of Tridaxprocumbens(Linn) (Asteraceae), the dried stem bark of Zanthoxylumzanthoxyloides(Lam) (Rutaceae) and the dried fruit buds of Eugenia caryophyllata(Thumb) (Mrytaceae).
Plant collection and authentication
The plants used were sourced from Mampong-Akwapem and its environs in 
Plant preparation
The various plant materials were air-dried in a cool, dry place under shade for 2 weeks at temperatures between 23ºC and 27ºC. The materials were pulverized using a hammer mill through 2mm screen. Each powdered plant material was extracted by macerating 1kg of the powdered plant material in 5 L of 70 % ( v / v ) ethanol for 3 days and then filtered. The ethanol was recovered using the rotary evaporator (Buchi™ R210) and the fluid extract evaporated on a water bath over 72hrs.
Composition of the product
The individual herbal extracts were combined according to the established recipe used by the CSRPM in the formulation of the product.
Standardisation of the product
The standardisation of the product involved two methods: the basic phytochemical screening and the thin layer chromatography.
In the basic phytochemical screening, the ointment, the total crude extracts and the individual plant materials were each screened for the presence of alkaloids, saponins, flavonoids, sterols/triterpenes, anthracenosides and cyanogenic glycosides using methods described. [16] [17] The thin layer chromatography was also performed for the ointment, the total crude extracts and the plant materials according to the methods prescribed. [18] [19] The total crude extract (TC) and the ointment were extracted in 70 % ( V / v ) of ethanol for three days. The aqueous fraction from this extraction was obtained by evaporating the ethanol using the rotary evaporator. This aqueous fraction was then extracted with ethyl acetate in a separating funnel (1:2) ( v / v ). The ethyl acetate fraction was spotted for the TLC on precoated silica gel 60 F 254 plates (Merck). Detection was done using an Ultraviolet Lamp at 365nm and 254 nm and anis aldehyde detecting reagent at ambient temperature.
Stability studies of the product
The stability of the product was tested by employing the methods of the thin layer chromatography, an antimicrobial assay and assessing the physical properties of the ointment. These studies were conducted at the baseline month 0, month 6, month 9 and month 12.
[20]
Thin layer chromatography
The thin layer chromatography was performed according to the guidelines described under the standardisation of the product.
Antimicrobial assay
The agar well diffusion method was used for the antimicrobial assay as described in the B.P, (1988) .An amount of 16g of the ointment was dissolved in 100mLof 20% dimethylsulphoxide (DMSO). Petri dishes of 100mm were filled with 25mLof sabouraud agar for the fungal organisms and 25mLof Mueller Hinton for the bacterial organisms. The plates were filled to a depth of 4mm and allowed to solidify. Each plate was then flooded with the pathogenic micro-organism and the plates were allowed drying at room temperature for one hour. A sterilised borer of an internal diameter of 4mm was used to bore holes in the media. The herbal products were dispensed into the bored holes. The filled petri dishes were kept in the refrigerator for 6 hrs to allow absorption of the extract into the media and then incubated at 27 o C for 72hrs for the fungal organisms and 38 o C for 24hrs for the bacterial organisms. DMSO was used as the negative control for all test organisms while fluconazole was used as the positive control for the fungal organisms and chloramphenicol for the bacterial organisms. After the incubation period, the diameter of each zone of inhibition was measured in millimetres with a metre rule. The measure of the zone of inhibition at each period of assay was compared and used as an indicator of the stability of the product.
Organoleptics
The organoleptic features: colour, odour and consistencyof the product were observed over the duration of the stability studies. Observations were made by two independent investigators.
pH
An amount of 1g of the ointment was dispersed in 100mL of distilled water by vigorous shaking and warming over a water bath to melt the ointment. The mixture was allowed to cool under room temperature to separate the insoluble wax from the aqueous phase. The insoluble wax was then decanted and the pH of the aqueous fraction determined using the digital pH meter (Cyberscan pH 310; EutechInst). [18] Preclinical chronic toxicity testing of the product Skin sensitisation and chronic toxicity was conducted for the product to identify any possible toxic effects. All experiments were performed according to the protocol described by Nyarko et al. and conducted in accordance with accepted principles for laboratory animal use and care (EU directive of 1986: 86/609/EEC). [18] 
Animals
Male Sprague-Dawley rats (200-250g) were used for the study. Animals were fed on powdered feed from Ghana Agro Food Company (GAFCO) Tema, Ghana and also allowed free access to sterilized distilled water.
Skin sensitization
The hair on the lateral portion of albino rats (about 9cm 3 ) was trimmed and shaved with a razor blade. The rats were divided into 5 groups (n=5). One group was injected intradermally with 0.1mL of 5% ( w / v ) of the highest dose of the ointment dissolved in glycerol. The control was also received an intradermal injection of 0.1Ml glycerol. The duration of the resultant swelling was observed, as well as any ulceration that appeared subsequently. The various dosage concentrations of the ointment were also applied topically to the three (3) groups of rats and the animals were observed daily for 6 months for any ulceration, irritation and/or inflammation. The last group did not receive any treatment and served as the control.
Chronic toxicity
Four groups of five rats each were kept in three different metal cages. Group 1 was kept as control and they received sterilised 
Haematological, biochemical and urine analyses
Blood samples were obtained by tail bleeding (at baseline, 1st, 3rd and 6th month) into Eppendorf tubes without anticoagulant. Samples were centrifuged for 5 mins (Denley BS 400, England) and the serum stored at -40 o C for biochemical analysis. Blood samples were also collected for haematological analysis.
Haematological analysis was done using Haema-Screen 18 (Hospitex Diagnostics, Italy) according to the established protocol. Serum biochemical analysis was also done using protocols from Cypress Diagnostic Kits (Belgium) with a semi-automated blood chemistry analyser, photometer 4040. Urine samples were also collected and analysed for specific gravity, pH, glucose, bilirubin, ketones, proteins, urobilinogen,
nitrates, blood and leucocytes using urine reagent strip UroColor™ 10 (Standard Diagnostic Inc., Korea).
Histology
Two rats from each group were euthanized after 6 months of treatment. Biopsies were taken from the liver, spleen, kidneys and skin. The skin biopsy was obtained from the area where the ointment was applied. Specimen was preserved in 10% formaldehyde solution (formalin). Tissues were embedded in paraffin wax, sectioned into uniform thickness of 10 μm and stained with hematoxylin and eosin. Sectioned tissues were evaluated under a microscope for any morphological changes.
Statistical analysis
One-way analysis of variance (ANOVA) and independent sample t-test was conducted to determine statistical significance.
Statistical tests were performed with Graphpad Prism software version 5.0 at an α-level of 5%.
RESULTS
Standardisation of the product
The results of the phytochemical screening showed the presence of alkaloids, phenols, sterols and triterpenes and flavonoids in the product. The results are compared to that of the individual plant extracts and the total crude extract in Table 2 . No differences were observed between the plant extract, total crude extract and the ointment. The thin layer chromatograph provided three analytical markers for the product (Figure 1) . The R f values of the spots were A (0.87), B (0.64) and C (0.57).
Table1: Voucher specimen number of plant materials used
Plant Material
Voucher Specimen Number Alchorneacordifolia CSRPM 368
Psidiumguajava
CSRPM 50
Tridaxprocumbens
CSRPM 256
Zanthoxylumzanthoxyloides CSRPM 330
Eugenia caryophyllata CSRPM 001CM
Stability studies of the product Thin layer Chromatography
The chromatographic finger print obtained for the ointment and the total crude extract was repeated over a year period. The values obtained for each period of time were not different ( Figure 2 ).The baseline and after one year of study for both test samples showed the ointment and the crude extracts to be stable as the spots obtained at the end of the study were not different from that obtained at the start of the study. Similar R f values were recorded A (0.87), B (0.64) and C (0.57).
Antimicrobial assay
The antimicrobial assay of the ointment against three fungal pathogens: Micosporumcanis, Trichophytonrubrum, and Candida albicans and one bacterial pathogen (Staphylococcus aureus) produced similar results over the one year study period (Table 3 ). The differences observed in the readings were not significantly different at the start of the Dickson et al.: Polyherbal product EAF-2011 and superficial mycoses study and after one year. The ointment also showed appreciable activity against the bacterial pathogen.
Organoleptic characters and pH
The study of the organoleptic characters of the ointment at the baseline showed the ointment to be dark brown in colour, aromatic in odour, smooth with no lumps or grittiness in consistency. These same observations were made subsequently in the following period of study as shown in Table 4 . A marginal change in pH values was recorded at the end of the study. The pH was recorded at the start of the study and during the study. This is also recorded in Table 4 . Table 4 : Organoleptic characters and pH of the ointment during the stability study Key: ALT -Alanine Transaminase, AST -Aspartate Transaminase, GGT -Gamma GlutamylTransferase, ALP -Alkaline Phosphatatse. No significant difference was observed (p<0.05) were observed between the test and control animals for all parameters in all the treatment groups. Implying the ointment has no harmful effect on the liver and kidneys. Results are Mean ± SEM; n=5 Preclinical chronic toxicity tests of the product Skin sensitivity testing
Alchorneacordifolia (AC), Zanthoxylumzanthoxyloides (ZZ), Psidiumguajava (PG), Eugenia caryophyllata (EG), Total crude extract (TC) and the ointment (OM).
The skin sensitivity test using the male Sprague-Dawley rats showed no dermal irritation in the form of ulcerations was observed during the 6 months of treatment. Subcutaneous papule that was formed after intradermal injection of the ointment dissolved in glycerol resolved without any ulceration after 72hrs of observation as in the control treatment.
Chronic toxicity studies
The results from the chronic toxicity study indicated that the ointment did not cause any significant change in the haematological, biochemical and urine parameters after 6 months of administration. The results of the haematological, biochemical and urine parameters are shown in Table 5 , 6 and 7 respectively.
Histology
The gross features of the organs isolated after termination were detected to have no abnormalities. No significant differences were observed in the organ weights between the control and the herbal treatments (Table  8) . Microscopic examination of the tissues did not indicate any histopathological changes to the tissues sampled. The skin epidermis, dermis and adnexal tissues were regular in pattern. The spleen had regular red and white pulps with some haemosiderin deposition which was considered as physiological. In the kidneys the glomeruli, tubules and interstitium were normal. There was no indication of an inflammation or necrosis. The liver's portal tracts, hepatocytes and sinusoids were normal with the absence of inflammation or fibrosis. There was also no hepatocyte degeneration. These features were identified in the Whitfield, 2 %, 5 % and 10 % herbal treatment. Samples micrographs from histopathology are shown in Figures  3-6 .
DISCUSSION
The quality evaluation of medicinal products has become a key component in the assessment of herbal medicines. The value of these studies for natural products cannot be overemphasised as the variability in medically active constituents in these products has implications on the therapeutic effects produced by them. [21] Standardisation of all natural remedies has been touted as a solution to this challenge. [21] The basic phytochemical screening of the product EAF-2011 indicated the presence of secondary metabolites like the alkaloids, phenols, flavonoids, sterol and triterpenesin the product. The results apart from providing a standard, also corroborates the indication given to the product as some compounds belonging to this class of secondary metabolites detected have shown some antifungal activity. Ursolic acid a triterpene found in Psidiumguajava has been reported for its antifungal activity against Candida albicans.
[20] Quercetin and kaempferolall flavonoids previously identified in Eugenia caryophyllata, Psidiumguajava and Tridaxprocumbenshave also showed some antifungal activity. [23] Alkaloids like the berberine and furoquinoline have been reported to be active againstTrichophyton,Epidermophyton, Micosporum and Candida species isolated from some individuals with dermatophytosi. [24] [25] These two alkaloids are noted to be present in Zanthoxylumzanthoxyloidesone of the plants in the product. The activity of the product can hence be attributed to the presence of these secondary metabolites.
Despite the importance of the basic phytochemical screening in standardisation, the use of multiple methods in this process provides a more reliable guarantee about the quality of products. [26] A confirmation to this statement has been made by some authors who have suggested methods of standardisation that have been classified under the broad categories of physical, botanical, chemical and biological standardisation.
[26-27] These suggestions make the results of the thin layer chromatography, antimicrobial assay and the physicochemical properties employed during the stability study also relevant for the process of standardisation.
[27] Also, the markers obtained by the thin layer chromatography; shown to be mostly phenolic compounds by their colour, can be considered as analytical markers for the product based on their stability and adequate detection with little interference (Figures 1and 2) . [28] The markers from the individual plant can be used for monitoring the quality of plant materials collected and during the manufacturing process as they were shown on the chromatograph to contribute to the markers in the final product. [28] With the safety of herbal medicinal products considered as relevant as any other procedures in the drug evaluation process, it is important that the product did not induce any change in the haematological, biochemical and urine parameters which by extension means that the product was not likely to have any harmful effect on the human subjects (Tables 6 to 8) . [14] The skin sensitivity ruled out any irritations and immune response that may be elicited on the administration of the product a finding that was further confirmed on the histopathological examination of the sampled skin tissue by the absence of immuno-modulatory structures like the mast cells. [29] These results are important despite the product having some history of use in humans because the reliance on data from folkloric knowledge for safety has its own limitation such as the inability to detect toxic effects that develop in long term usage and those that occur as a result of hypersensitivity to the products. [30] 
CONCLUSION
The results from the study showed the product, EAF 2011, to be of good quality (stable) over the study period as well as safe for use under the specified conditions of the experiment.Despite the fact that only one mammalian specie (rats) was used in the study for the safety, the long history of use enables a less stringent assessment to be made on the product. Also, data obtained from the studyprovides a monograph for the product to guarantee quality in subsequent products.
